Dimerix Limited

ASX (AUD): Dimerix Limited (DXB)

Last Price

0.50

Today's Change

+0.02 (4.16%)

Day's Change

0.465 - 0.515

Trading Volume

7,060,302

Profile
DXB

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Nina Webster B.Sc., M.B.A., M.IP.Law, MBA, Ph.D. Dr. Nina Webster B.Sc., M.B.A., M.IP.Law, MBA, Ph.D.

Full Time Employees:  0 0

IPO Date:  1989-07-31 1989-07-31

CIK: 

ISIN:  AU000000DXB7 AU000000DXB7

CUSIP:  Q3191W104 Q3191W104

Beta:  0.50 0.50

Last Dividend:  0.00 0.00

Dcf Diff:  0.51 0.51

Dcf:  -0.01 -0.01

Description

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

Address

425 Smith Street,
Fitzroy, VIC 3065, AU

1300 813 321

http://dimerix.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment